跳至主要内容
临床试验/NCT05697328
NCT05697328招募中不适用

Pseudoephedrine Prophylaxis for Prevention of Middle Ear Barotrauma in Hyperbaric Oxygen Therapy

John Muir Health1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年1月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
1
主要终点
Compare changes in self-reported ear pain during hyperbaric oxygen therapy

研究概览

简要总结

The purpose of this research is to study whether the use of pseudoephedrine can help prevent middle ear trauma during HBOT. Pseudoephedrine is an approved drug that is used for temporary relief of nasal or sinus pain and pressure.

详细描述

Subjects will be asked to take a pill (pseudoephedrine or placebo) between 45 and 120 minutes before hyperbaric oxygen therapy. Subjects' ears will be examined before and after therapy and be asked to assess ear pain. There will be no further tests or procedures after completion of therapy session and ear examinations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double-blind placebo control

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New patient requiring HBOT (either inpatient or outpatient)
  • Age greater than or equal to 18 years and less than 80 years
  • Fluent in English
  • Full decision capacity
  • Able and medically cleared to swallow a pill

排除标准

  • Enrollment would delay hyperbaric therapy more than 30 minutes in patients with emergent indications (example: Central Retinal Arterial Occlusion, Carbon Monoxide, Air Gas Embolism)
  • Contraindication to pseudoephedrine (monoamine oxidase inhibitors (MAOI) use, pregnancy, glaucoma, heart disease, allergy to drug class)
  • Systolic Blood Pressure >160
  • Diastolic Blood Pressure > 90
  • Heart Rate >100
  • Decongestant/antihistamine/pseudoephedrine/nasal steroid/oxymetazoline use within 12 hours.
  • Intubated
  • Unable to swallow oral medications

研究组 & 干预措施

Pseudoephedrine

Experimental

over the counter pseudoephedrine

干预措施: Pseudoephedrine Pill (Drug)

Placebo

Placebo Comparator

pharmacy created placebo capsule

干预措施: Placebo (Drug)

结局指标

主要结局

Compare changes in self-reported ear pain during hyperbaric oxygen therapy

时间窗: 45-60 minutes

Patients to describe pain on a numerical scale before, during and after hyperbaric oxygen therapy

次要结局

  • Incidence of completed compression(1 minute)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jacinta Showers

Principal Investigator

John Muir Health

研究点 (1)

Loading locations...

相似试验

Barotrauma in Hyperbaric Oxygen Therapy | 临床试验